Market Cap : 1.77 B | Enterprise Value : 1.6 B | PE Ratio : | PB Ratio : 19.34 |
---|
NAS:IMGN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:IMGN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Immunogen's quarterly additional paid-in capital increased from Mar. 2020 ($1,310.7 Mil) to Jun. 2020 ($1,314.6 Mil) and increased from Jun. 2020 ($1,314.6 Mil) to Sep. 2020 ($1,318.6 Mil).
Immunogen's annual additional paid-in capital increased from Dec. 2017 ($1,009.4 Mil) to Dec. 2018 ($1,192.8 Mil) and increased from Dec. 2018 ($1,192.8 Mil) to Dec. 2019 ($1,209.8 Mil).
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.
Additional Paid-In Capital is calculated as
Additional Paid-In Capital | = | (Issue Price | - | Par Value) | * | Shares Outstanding (Diluted Average) |
No Headline